arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Elanco Animal Health Inc

ELAN

$22.10 ▼ -2.09 (-8.66%) at close

11 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Elanco Animal Health Inc faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $11.0B

Dividend Yield —

Revenue Growth 6.2% ↗

Op. Margin —

ROIC —

FCF / Share $0.57 ↘

Trailing P/E —

Price / Book 1.7x

FCF Yield 2.6%

Debt / Equity 0.57

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.71B

↑ +6.2% —

Net Income Profit after all expenses

$-232.00M

↓ -168.6% —

FCF / Share Free cash flow per share

$0.57

↓ -28.3% —

Long-Term Debt Long-term obligations

$3.76B

↓ -12.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability →

Returns ↑

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	6.2% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-22%)	0.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-94%)	0.1% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-98%)	-7.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-193%)	45.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+469%)	6.6% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-18%)	0.1% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-98%)	6.2% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-23%)	-0.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-111%)	—	—
EPS Growth YoY (%)	N/M	N/M	-1462.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	83.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	22.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	-35.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	-1478.2% Weak ↓ Weak Declining Year-over-year change in net income	83.9% Excellent ↑ Excellent Improving Year-over-year change in net income	13.8% Fair Fair Year-over-year change in net income	N/M	-21.5% Weak Weak Year-over-year change in net income	N/M	-548.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-28.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	199.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-58.8% Weak Weak Year-over-year change in free cash flow	-12.0% Weak Weak Year-over-year change in free cash flow	N/M	N/M	-79.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	2.2% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	-2.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	10.5% Good → Good Stable Compound annual revenue growth over 3 years	12.8% Good ↑ Good Improving Compound annual revenue growth over 3 years	15.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	4.2% Caution Caution Compound annual revenue growth over 3 years	1.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	7.6% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	7.6% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	7.6% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	8.8% Good Good Compound annual revenue growth over 5 years	10.3% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Effective Tax Rate (%) (%)	-3.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	30.7% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-8.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.4% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.7% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.2% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-33.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-113.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-4.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	7.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	-27.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-332%)	-1.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-115%)	-10.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-184%)	-17.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	2.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-82%)	2.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-76%)	-10.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-190%)	-1.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-114%)	—
FCF Margin (%) (%)	6.0% Caution → Caution Stable Free cash flow as a percentage of revenue Optimal: > 10%	8.9% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	3.0% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	7.1% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	7.5% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	11.5% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	2.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	1.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-1.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.11x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.74x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	4.08x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.24x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.95x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Common Equity (%) (%)	-3.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	5.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	-19.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	-1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	-6.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-6.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	1.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-92%)	1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	-4.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-0.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-105%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	0.57x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.71x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+18%)	0.93x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+55%)	0.80x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+33%)	0.84x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+40%)	0.72x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+20%)	0.42x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.48x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—
Net Debt (USD)	$3.22B	$3.85B	$5.42B	$5.49B	$5.68B	$5.63B	$2.02B	$2.00B	$-323.40M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$9.50	$8.99	$8.97	$9.03	$9.78	$7.42	$8.32	$9.78	—	$9.93	—
Basic EPS, GAAP (USD)	$-0.47	$0.68	$-2.50	$-0.16	$-0.99	$-1.27	$0.18	$0.28	—	—	—
Free Cash Flow per Share (USD)	$0.57	$0.80	$0.27	$0.65	$0.73	$-0.40	$0.23	$1.12	—	$0.16	—
Book Value per Share (USD)	$13.17	$12.33	$12.63	$15.37	$15.87	$17.96	$14.87	$14.21	—	$23.93	—
Tangible Book Value per Share (USD)	$-3.30	$-4.04	$-6.83	$-7.48	$-8.99	$-8.76	$0.20	$-0.73	—	$23.93	—
Basic Weighted Avg Shares (shares)	496.40M	494.00M	492.30M	488.30M	487.20M	441.40M	369.00M	313.70M	—	293.29M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$1.86B	$1.90B	$2.17B	$1.58B	$1.63B	$1.34B	$1.55B	$1.53B	$1.48B	—	—
LT Debt (USD)	$3.76B	$4.32B	$5.77B	$5.84B	$6.32B	$6.13B	$2.35B	$2.47B	$0.00	—	—
Total Equity (USD)	$6.55B	$6.10B	$6.22B	$7.29B	$7.51B	$8.48B	$5.55B	$5.20B	$7.78B	$7.02B	$7.43B

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$4.71B	$4.44B	$4.42B	$4.41B	$4.76B	$3.27B	$3.07B	$3.07B	$2.89B	$2.91B	—
Depreciation Expense (USD)	$680.00M	$662.00M	$694.00M	$682.00M	$716.00M	$517.00M	$314.50M	$296.00M	$318.40M	$254.40M	—
Net Income, GAAP (USD)	$-232.00M	$338.00M	$-1.23B	$-78.00M	$-483.00M	$-560.00M	$67.90M	$86.50M	$-310.70M	$-47.90M	—
Operating Cash Flow (USD)	$560.00M	$541.00M	$271.00M	$452.00M	$483.00M	$-41.00M	$224.10M	$487.30M	$173.80M	$155.90M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 38 quarters

Elanco Animal Health Inc

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ELAN with peers